← Open Payments lookup

ALAN LOPEZ: Open Payments

NPI 1689429326 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$573 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,057 · 2025 $573

Food & beverage: $573
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$136
ABBVIE INC.3$73
E.R. Squibb & Sons, L.L.C.3$67
Axsome Therapeutics, Inc.3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$55
Otsuka America Pharmaceutical, Inc.2$53
Alkermes, Inc.2$51
Teva Pharmaceuticals USA, Inc.2$42
Novo Nordisk Inc1$19
Lundbeck LLC1$17

Products named: INGREZZA, VRAYLAR, REXULTI, COBENFY, Auvelity, CAPLYTA, ARISTADA, UZEDY.

Industry payments across NV — which companies pay providers there.